ATYR logo

ATYR
aTyr Pharma, Inc

13,719
Mkt Cap
$94.62M
Volume
2.79M
52W High
$7.29
52W Low
$0.6816
PE Ratio
-1.21
ATYR Fundamentals
Price
$0.9656
Prev Close
$0.9728
Open
$0.9879
50D MA
$2.68
Beta
0.65
Avg. Volume
21.17M
EPS (Annual)
-$0.8621
P/B
1.20
Rev/Employee
$3,983.05
Loading...
Loading...
News
all
press releases
ATYR Investor Alert: New aTyr Pharma, Inc. (ATYR) Securities Class Filed; Class Period Significantly Enlarged -- Hagens Berman
ATYR Investor Alert: New aTyr Pharma, Inc. (ATYR) Securities Class Filed; Class Period Significantly Enlarged -- Hagens Berman ATYR Investor Alert: New aTyr Pharma, Inc. (ATYR) Securities Class...
PR Newswire·1d ago
News Placeholder
More News
News Placeholder
aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud...
PR Newswire·1d ago
News Placeholder
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 8, 2025 in aTyr Pharma, Inc. Lawsuit - ATYR
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 8, 2025 in aTyr Pharma, Inc. Lawsuit - ATYR Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of...
PR Newswire·1d ago
News Placeholder
Deadline Alert: aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
Glancy Prongay & Murray LLP reminds investors of the upcoming December 8, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise...
Business Wire·2d ago
News Placeholder
ATYR INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma
ATYR INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma ATYR INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on...
PR Newswire·2d ago
News Placeholder
The Gross Law Firm Notifies Shareholders of aTyr Pharma, Inc.(ATYR) of a Class Action Lawsuit and an Upcoming Deadline
The Gross Law Firm Notifies Shareholders of aTyr Pharma, Inc.(ATYR) of a Class Action Lawsuit and an Upcoming Deadline The Gross Law Firm Notifies Shareholders of aTyr Pharma, Inc.(ATYR) of a Class...
PR Newswire·2d ago
News Placeholder
Deadline Approaching: aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
Law Offices of Howard G. Smith reminds investors of the upcoming December 8, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased aTyr Pharma Inc...
Business Wire·3d ago
News Placeholder
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages aTyr Pharma Inc. (ATYR) Shareholders To Inquire About Securities Fraud Class Action
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise...
Business Wire·4d ago
News Placeholder
Shareholders of aTyr Pharma, Inc. Should Contact Levi & Korsinsky Before December 8, 2025 to Discuss Your Rights - ATYR
Shareholders of aTyr Pharma, Inc. Should Contact Levi & Korsinsky Before December 8, 2025 to Discuss Your Rights - ATYR Shareholders of aTyr Pharma, Inc. Should Contact Levi & Korsinsky Before...
PR Newswire·4d ago
News Placeholder
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit PR Newswire NEW YORK, Oct. 21...
PR Newswire·5d ago

Latest ATYR News

View

Advertisement|Remove ads.

Advertisement|Remove ads.